IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 404

India’s cumulative vaccination coverage over 176.47 Crore. More than 26 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 176.47 Crore (1,76,47,86,112) today. More than 26 lakh (26,88,373Vaccine Doses have been administered till 7 pm today. More than 1.94 Crore (1,94,97,567) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10401091
2nd Dose 9960083
Precaution Dose 4110185
FLWs 1st Dose 18408618
2nd Dose 17429708
Precaution Dose 6033480
Age Group 15-18 years 1st Dose 54245330
  2nd Dose 24671636
Age Group 18-44 years 1st Dose 551066647
2nd Dose 439821026
Age Group 45-59 years 1st Dose 202152510
2nd Dose 179193735
Over 60 years 1st Dose 126309207
2nd Dose 111628954
Precaution Dose 9353902
Cumulative 1st dose administered 962583403
Cumulative 2nd dose administered 782705142
Precaution Dose 19497567
Total 1761575119

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 23rd February, 2022 (404th Day)
HCWs 1st Dose 87
2nd Dose 2401
Precaution Dose 16529
FLWs 1st Dose 147
2nd Dose 3201
Precaution Dose 24322
Age Group 15-18 years 1st Dose 139567
  2nd Dose 758193
Age Group 18-44 years 1st Dose 182043
2nd Dose 1055390
Age Group 45-59 years 1st Dose 28569
2nd Dose 222635
Over 60 years 1st Dose 22596
2nd Dose 139481
Precaution Dose 93212
Cumulative 1st dose administered 373009
Cumulative 2nd dose administered 2181301
Precaution Dose 134063
Total 2688373

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker